The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Updates on global epidemiology, risk and prognostic factors of gastric cancer
Open accessAbstract
Gastric cancer (GC) is defined as the primary epithelial malignancy derived from the stomach, and it is a complicated and heterogeneous disease with multiple risk factors. Despite its overall declining trend of incidence and mortality in various countries over the past few decades, GC remains the fifth most common malignancy and the fourth leading cause of cancer-related death globally. Although the global burden of GC has shown a significant downward trend, it remains severe in certain areas, such as Asia. GC ranks third in incidence and mortality among all cancer types in China, and it accounts for nearly 44.0% and 48.6% of new GC cases and GC-related deaths in the world, respectively. The regional differences in GC incidence and mortality are obvious, and annual new cases and deaths are increasing rapidly in some developing regions. Therefore, early preventive and screening strategies for GC are urgently needed. The clinical efficacies of conventional treatments for GC are limited, and the developing understanding of GC pathogenesis has increased the demand for new therapeutic regimens, including immune checkpoint inhibitors, cell immunotherapy and cancer vaccines. The present review describes the epidemiology of GC worldwide, especially in China, summarizes its risk and prognostic factors, and focuses on novel immunotherapies to develop therapeutic strategies for the management of GC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J. H., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055531 · Cited by 6,334
LAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C., & Lordick, F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31288-5 · Cited by 4,803
Molecular mechanisms of T cell co-stimulation and co-inhibition
Chen, L., & Flies, D. B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3405 · Cited by 3,114
Janjigian, Y. Y., Shitara, K., Moehler, M., Garrido, M., Salman, P., Shen, L., Wyrwicz, L., Yamaguchi, K., Skoczylas, T., Campos Bragagnoli, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00797-2 · Cited by 3,041
Kang, Y.-K., Boku, N., Satoh, T., Ryu, M.-H., Chao, Y., Kato, K., Chung, H. C., Chen, J.-S., Muro, K., Kang, W. K., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31827-5 · Cited by 2,252
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1057 · Cited by 1,879
Fuchs, C. S., Doi, T., Jang, R. W., Muro, K., Satoh, T., Machado, M., Sun, W., Jalal, S. I., Shah, M. A., Metges, J.-P., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0013 · Cited by 1,784
Self-citationGastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0008 · Cited by 1,684
Current treatment and recent progress in gastric cancer
Joshi, S. S., & Badgwell, B. D. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21657 · Cited by 1,677
Zeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30127-x · Cited by 1,546
Self-citationEpidemiology of gastric cancer: global trends, risk factors and prevention
Rawla, P., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.80001 · Cited by 1,540
Cancer incidence and mortality in China, 2016
Zheng, R., Zhang, S., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2022) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2022.02.002 · Cited by 1,494
Thrift, A. P., & El-Serag, H. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.045 · Cited by 1,456
Immune-related adverse events of checkpoint inhibitors
Ramos-Casals, M., Brahmer, J. R., Callahan, M. K., Flores-Chávez, A., Keegan, N., Khamashta, M. A., Lambotte, O., Mariette, X., Prat, A., & Suárez-Almazor, M. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0160-6 · Cited by 1,412
Health-promoting components of fruits and vegetables in the diet.
Liu, R. H. (2013) · Advances in Nutrition · doi:10.3945/an.112.003517 · Cited by 1,310
Chemotherapy for advanced gastric cancer
Wagner, A. D., Syn, N. L., Moehler, M., Grothe, W., Yong, W. P., Tai, B.-C., Ho, J., & Unverzagt, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004064.pub4 · Cited by 1,299
The Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080
Gastric cancer: epidemiology, prevention, classification, and treatment
Sitarz, R., Skierucha, M., Mielko, J., Offerhaus, J., Maciejewski, R., & Polkowski, W. (2018) · Cancer Management and Research · doi:10.2147/cmar.s149619 · Cited by 1,026
Clinton, S. K., Giovannucci, E. L., & Hursting, S. D. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxz268 · Cited by 973
Plummer, M., Franceschi, S., Vignat, J., Forman, D., & de Martel, C. (2015) · International Journal of Cancer · doi:10.1002/ijc.28999 · Cited by 957
CAR T Cell Therapy for Solid Tumors
Newick, K., O'Brien, S., Moon, E., & Albelda, S. M. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-062315-120245 · Cited by 909
Gastric cancer: a comprehensive review of current and future treatment strategies
Sexton, R. E., Al Hallak, M. N., Diab, M., & Azmi, A. S. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09925-3 · Cited by 772
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
Janjigian, Y. Y., Kawazoe, A., Yañez, P., Li, N., Lonardi, S., Kolesnik, O., Barajas, O., Bai, Y., Shen, L., Tang, Y., et al. (2021) · Nature · doi:10.1038/s41586-021-04161-3 · Cited by 720
Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota
Ferreira, R. M., Pereira-Marques, J., Pinto-Ribeiro, I., Costa, J. L., Carneiro, F., Machado, J. C., & Figueiredo, C. (2018) · Gut · doi:10.1136/gutjnl-2017-314205 · Cited by 697
Janjigian, Y. Y., Bendell, J., Calvo, E., Kim, J. W., Ascierto, P. A., Sharma, P., Ott, P. A., Peltola, K., Jaeger, D., Evans, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.6212 · Cited by 624
Ferro, A., Peleteiro, B., Malvezzi, M., Bosetti, C., Bertuccio, P., Levi, F., Negri, E., La Vecchia, C., & Lunet, N. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.029 · Cited by 617
Soerjomataram, I., Lortet-Tieulent, J., Parkin, D. M., Ferlay, J., Mathers, C., Forman, D., & Bray, F. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60919-2 · Cited by 598
Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y., & Moayyedi, P. (2014) · BMJ · doi:10.1136/bmj.g3174 · Cited by 580
Hartmann, J., Schüßler‐Lenz, M., Bondanza, A., & Buchholz, C. J. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607485 · Cited by 532
Arnold, M., Karim-Kos, H. E., Coebergh, J. W., Byrnes, G., Antilla, A., Ferlay, J., Renehan, A. G., Forman, D., & Soerjomataram, I. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2013.09.002 · Cited by 513
Smoking and gastric cancer: systematic review and meta-analysis of cohort studies
Ladeiras-Lopes, R., Pereira, A. K., Nogueira, A., Pinheiro-Torres, T., Pinto, I., Santos-Pereira, R., & Lunet, N. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9132-y · Cited by 511
Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
Arnold, M., Park, J. Y., Camargo, M. C., Lunet, N., Forman, D., & Soerjomataram, I. (2020) · Gut · doi:10.1136/gutjnl-2019-320234 · Cited by 504
Updates on Management of Gastric Cancer
Johnston, F. M., & Beckman, M. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0820-4 · Cited by 495
Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits
Graham, D. Y. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.040 · Cited by 454
Engineering and Design of Chimeric Antigen Receptors
Guedan, S., Calderon, H., Posey, A. D., & Maus, M. V. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.12.009 · Cited by 453
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
Shitara, K., Ajani, J. A., Moehler, M., Garrido, M., Gallardo, C., Shen, L., Yamaguchi, K., Wyrwicz, L., Skoczylas, T., Bragagnoli, A. C., et al. (2022) · Nature · doi:10.1038/s41586-022-04508-4 · Cited by 449
Familial gastric cancer: genetic susceptibility, pathology, and implications for management
Oliveira, C., Pinheiro, H., Figueiredo, J., Seruca, R., & Carneiro, F. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71016-2 · Cited by 427
Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review
Tan, Z. (2019) · Medical Science Monitor · doi:10.12659/msm.916475 · Cited by 427
Global Incidence and Mortality of Gastric Cancer, 1980-2018
Wong, M. C. S., Huang, J., Chan, P. S. F., Choi, P., Lao, X. Q., Chan, S. M., Teoh, A., & Liang, P. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.18457 · Cited by 408
Advances in clinical immunotherapy for gastric cancer
Li, K., Zhang, A., Li, X., Zhang, H., & Zhao, L. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188615 · Cited by 405
Characteristics of gastric cancer in Asia
Rahman, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4483 · Cited by 404
Cancer incidence and mortality in China, 2015
Zhang, S., Sun, K., Zheng, R., Zeng, H., Wang, S., Chen, R., Wei, W., & He, J. (2021) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2020.12.001 · Cited by 389
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015
Jung, K.-W., Won, Y.-J., Kong, H.-J., Lee, E. S., & Registries, T. C. O. P.-B. R. C. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2018.143 · Cited by 386
Habitual salt intake and risk of gastric cancer: A meta-analysis of prospective studies
D’Elia, L., Rossi, G., Ippolito, R., Cappuccio, F. P., & Strazzullo, P. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.01.003 · Cited by 383
Peleteiro, B., Bastos, A., Ferro, A., & Lunet, N. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3063-0 · Cited by 315
The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies
Shi, L., Chen, S., Yang, L., & Li, Y. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-74 · Cited by 307
for the JPHC Study Group, Tsugane, S., Sasazuki, S., Kobayashi, M., & Sasaki, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601511 · Cited by 297
Current cancer burden in China: epidemiology, etiology, and prevention
Cao, M., Li, H., Sun, D., He, S., Yan, X., Yang, F., Zhang, S., Xia, C., Lei, L., Peng, J., et al. (2022) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2022.0231 · Cited by 287
Surgical Management of Gastric Cancer: A Review
Li, G. Z., Doherty, G. M., & Wang, J. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.0182 · Cited by 278
Self-citationThe Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites
Anderson, W. F., Rabkin, C. S., Turner, N., Fraumeni, J. F., Rosenberg, P. S., & Camargo, M. C. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx262 · Cited by 270
Fang, X., Wei, J., He, X., An, P., Wang, H., Jiang, L., Shao, D., Liang, H., Li, Y., Wang, F., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.09.010 · Cited by 264
Ralph, C., Elkord, E., Burt, D. J., O'Dwyer, J. F., Austin, E. B., Stern, P. L., Hawkins, R. E., & Thistlethwaite, F. C. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2870 · Cited by 250
Jiang, H., Shi, Z., Wang, P., Wang, C., Yang, L., Du, G., Zhang, H., Shi, B., Jia, J., Li, Q., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy134 · Cited by 247
Cancer incidence and mortality in China in 2013: an analysis based on urbanization level
Chen, W., National Central Cancer Registry, N. C. C. H., Zheng, R., Zhang, S., Zeng, H., Zuo, T., Xia, C., Yang, Z., & He, J. (2017) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2017.01.01 · Cited by 239
Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis
Luo, G., Zhang, Y., Guo, P., Wang, L., Huang, Y., & Li, K. (2017) · International Journal of Cancer · doi:10.1002/ijc.30835 · Cited by 230
Kawazoe, A., Kuwata, T., Kuboki, Y., Shitara, K., Nagatsuma, A. K., Aizawa, M., Yoshino, T., Doi, T., Ohtsu, A., & Ochiai, A. (2017) · Gastric Cancer · doi:10.1007/s10120-016-0631-3 · Cited by 225
LI, L. F., CHAN, R. L. Y., LU, L., SHEN, J., ZHANG, L., WU, W. K. K., WANG, L., HU, T., LI, M. X., & CHO, C. H. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1786 · Cited by 224
Treatment of Helicobacter pylori infection: Current status and future concepts
Yang, J.-C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5283 · Cited by 222
Miho, E., Yermanos, A., Weber, C. R., Berger, C. T., Reddy, S. T., & Greiff, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00224 · Cited by 189
Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells
Wu, L., Wei, Q., Brzostek, J., & Gascoigne, N. R. J. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0470-3 · Cited by 173
National cancer incidence and mortality in China, 2012.
Chen, W., Zheng, R., Zuo, T., Zeng, H., Zhang, S., & He, J. (2016) · PubMed · doi:10.3978/j.issn.1000-9604.2016.02.08 · Cited by 169
Ibrahim, A., Morais, S., Ferro, A., Lunet, N., & Peleteiro, B. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.03.019 · Cited by 169
Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?
Durães, C., Almeida, G. M., Seruca, R., Oliveira, C., & Carneiro, F. (2014) · Virchows Archiv · doi:10.1007/s00428-013-1533-y · Cited by 168
Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles
Erawijantari, P. P., Mizutani, S., Shiroma, H., Shiba, S., Nakajima, T., Sakamoto, T., Saito, Y., Fukuda, S., Yachida, S., & Yamada, T. (2020) · Gut · doi:10.1136/gutjnl-2019-319188 · Cited by 164
Regulation of Helicobacter pylori cagA Expression in Response to Salt
Loh, J. T., Torres, V. J., & Cover, T. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4746 · Cited by 162
[Report of Cancer Incidence and Mortality in China, 2014].
Chen, W., Li, H., Sun, K., Zheng, R., Zhang, S. W., Zeng, H., Zou, X. N., Gu, X., & He, J. (2018) · PubMed · doi:10.3760/cma.j.issn.0253-3766.2018.01.002 · Cited by 156
Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
Jin, X., Liu, Z., Yang, D., Yin, K., & Chang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.948647 · Cited by 156
Bang, Y., Choi, Y., Kim, Y. H., Kim, J. W., Bartolomeo, M. D., Ajani, J. A., Yamaguchi, K., Balogh, Á., Sánchez, T., & Moehler, M. H. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0025 · Cited by 155
Zhang, M., Dong, Y., Liu, H., Wang, Y., Zhao, S., Xuan, Q., Wang, Y., & Zhang, Q. (2016) · Scientific Reports · doi:10.1038/srep37933 · Cited by 154
P53 codon 72 polymorphism and gastric cancer: A meta‐analysis of the literature
Zhou, Y., Li, N., Zhuang, W., Liu, G., Wu, T., Yao, X., Du, L., Wei, M., & Wu, X. (2007) · International Journal of Cancer · doi:10.1002/ijc.22833 · Cited by 142
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
Lv, J., Zhao, R., Wu, D., Zheng, D., Wu, Z., Shi, J., Wei, X., Wu, Q., Long, Y., Lin, S., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0704-y · Cited by 141
Self-citationAreia, M., Carvalho, R., Cadime, A. T., Gonçalves, F. R., & Dinis-Ribeiro, M. J. (2013) · Helicobacter · doi:10.1111/hel.12050 · Cited by 135
Sjödahl, K., Lu, Y., Nilsen, T. I. L., Ye, W., Hveem, K., VATTEN, L. J., & Lagergren, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22157 · Cited by 134
Helicobacter pylori infection and gastric cancer
Lochhead, P. J., & El-Omar, E. M. (2007) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.02.002 · Cited by 132
Gonzalez, C. A., Mégraud, F., Buissonnière, A., Luján‐Barroso, L., Agudo, A., Duell, E. J., Boutron‐Ruault, M., Clavel‐Chapelon, F., Palli, D., Krogh, V., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr384 · Cited by 132
Alcohol consumption and gastric cancer risk—A pooled analysis within the StoP project consortium
Rota, M., Pelucchi, C., Bertuccio, P., Matsuo, K., Zhang, Z., Ito, H. M., Hu, J., Johnson, K. C., Palli, D., Ferraroni, M., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30891 · Cited by 131
Alcohol consumption and risk of stomach cancer: A meta-analysis
Deng, W., Jin, L., Zhuo, H., Vasiliou, V., & Zhang, Y. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109365 · Cited by 120
Diet and Risk of Gastric Cancer: An Umbrella Review
Bouras, E., Tsilidis, K. K., Triggi, M., Siargkas, A., Chourdakis, M., & Haidich, A. (2022) · Nutrients · doi:10.3390/nu14091764 · Cited by 120
Song, Y., Tong, C., Wang, Y., Gao, Y., Dai, H., Guo, Y., Zhao, X., Wang, Y., Wang, Z., Han, W., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0384-8 · Cited by 115
Recent progress in Helicobacter pylori treatment
Hu, Y., Zhu, Y., & Lü, N. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000618 · Cited by 107
Progress of Gastric Cancer Surgery in the era of Precision Medicine
Wang, Y., Zhang, L., Yang, Y., Lü, S., & Chen, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.56735 · Cited by 106
Gong, J., Liu, T., Fan, Q., Bai, L., Bi, F., Qin, S., Wang, J., Xu, N., Cheng, Y., Bai, Y., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2092-9 · Cited by 104
Self-citationKim, M., Pyo, S., Kang, C. H., Lee, C. O., Lee, H. K., Choi, S. U., & Park, C. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198347 · Cited by 104
Molecular mimicry in Helicobacter pylori infections
Chmiela, M., & Gonciarz, W. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i22.3964 · Cited by 97
Bessède, E., & Mégraud, F. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.001 · Cited by 95
The association of cigarette smoking with gastric cancer: the multiethnic cohort study
Nomura, A. M. Y., Wilkens, L. R., Henderson, B. E., Epplein, M., & Kolonel, L. N. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9854-0 · Cited by 94
Immunotherapy of gastric cancer: Past, future perspective and challenges
Xie, J., Fu, L., & Li, J. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153322 · Cited by 91
Clinical Development of Immune Checkpoint Inhibitors
Ito, A., Kondo, S., Tada, K., & Kitano, S. (2015) · BioMed Research International · doi:10.1155/2015/605478 · Cited by 86
Prediction of Cancer Incidence and Mortality in Korea, 2014
Jung, K., Won, Y., Kong, H., Oh, C., Lee, D. H., & Lee, J. S. (2014) · Cancer Research and Treatment · doi:10.4143/crt.2014.46.2.124 · Cited by 86
Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer
Singh, S. P., & Jha, H. C. (2017) · Journal of Oncology · doi:10.1155/2017/3456264 · Cited by 84
Singh, H., Moyes, J. S. E., Huls, M. H., & Cooper, L. J. N. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2014.69 · Cited by 77
Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
Tao, K., He, M. Q., Tao, F., Xu, G., Ye, M., Zheng, Y., & Li, Y. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3670-0 · Cited by 77
Stomach cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies
Fortunato, L., & Rushton, L. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.599 · Cited by 71
Jafar, S., Amirzadeh, J., Nahedi, S., & Shahsavari, S. (2013) · PubMed · Cited by 68
Park, I., Ryu, M., Choi, Y. H., Kang, H. J., Yook, J. H., Park, Y. S., Kim, H. J., Jung, H., Lee, G. H., Kim, K. C., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2257-z · Cited by 51
Fecal Microbiome Alteration May Be a Potential Marker for Gastric Cancer
Wu, J., Zhang, C., Xu, S., Xiang, C., Wang, R., Yang, D., Lu, B., Shi, L., Tong, R., Teng, Y., et al. (2020) · Disease Markers · doi:10.1155/2020/3461315 · Cited by 49
Kurosawa, M., Kikuchi, S., Xu, J. J., & Inaba, Y. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04290.x · Cited by 48
Cai, H., Li, M., Deng, R., Wang, M., & Shi, Y. (2022) · Biomarker Research · doi:10.1186/s40364-022-00413-0 · Cited by 48
Bae, J., & Kim, E. H. (2016) · Epidemiology and Health · doi:10.4178/epih.e2016034 · Cited by 46
Ito, Y., Miyashiro, I., Ishikawa, T., Akazawa, K., Fukui, K., Katai, H., Nunobe, S., Oda, I., Isobe, Y., Tsujitani, S., et al. (2020) · Journal of Epidemiology · doi:10.2188/jea.je20190351 · Cited by 46
Toyoda, T., Tsukamoto, T., Hirano, N., Mizoshita, T., Kato, S., Takasu, S., Ban, H., & Tatematsu, M. (2008) · PubMed · doi:10.14670/hh-23.593 · Cited by 44
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
Subhash, V. V., Yeo, M. S., Tan, W. L., & Yong, W. P. (2015) · Journal of Immunology Research · doi:10.1155/2015/308574 · Cited by 43
Familial clustering in subgroups of gastric cancer stratified by histology, age group and location
Eto, K., Ohyama, S., Yamaguchi, T., Wada, T., Suzuki, Y., Mitsumori, N. N. M., Kashiwagi, H., Anazawa, S., Yanaga, K. K., & Urashima, M. (2006) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2006.04.005 · Cited by 38
Advances in cancer immunotherapy for gastroenterological malignancy
Kono, K. (2018) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12184 · Cited by 38
Immune evasion mechanisms and therapeutic strategies in gastric cancer
Ma, E., Wang, Z., Zhu, M., & Zhao, J. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i1.216 · Cited by 36
Meulendijks, D., Beerepoot, L. V., Boot, H., de Groot, J. W. B., Los, M., Boers, J. E., Vanhoutvin, S. A. L. W., Polée, M. B., Beeker, A., Portielje, J. E. A., et al. (2015) · Investigational New Drugs · doi:10.1007/s10637-015-0309-4 · Cited by 35
Qin, S., Ji, J., Xu, R., Wang, W., Tang, Y. C., Bi, F., Li, J., Wang, K., Xu, J., Fan, Q., et al. (2021) · The Oncologist · doi:10.1002/onco.13826 · Cited by 33
The clinicopathologic significance of estrogen receptors in human gastric carcinoma
Wesołowska, M., Pawlik, P., & Jagodziński, P. P. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.048 · Cited by 27
Toledo‐Stuardo, K., Ribeiro, C. H., Canals, A., Morales, M., Gárate, V., Rodríguez-Siza, J., Tello, S., Bustamante, M., Armisén, R., Matthies, D. J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645528 · Cited by 27
Abozeid, M., Rosato, A., & Sommaggio, R. (2017) · BioMed Research International · doi:10.1155/2017/5791262 · Cited by 25
Checkpoint inhibitors in immunotherapy of ovarian cancer
Wang, D., Guo, L., & Wu, X.-H. (2014) · Tumor Biology · doi:10.1007/s13277-014-2848-2 · Cited by 23
Self-citationQu, J., Qu, X., Li, Z., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128540 · Cited by 22
Zhang, T., Ma, S., Zhao, Y., Zhao, D., & Ling, X.-L. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s80913 · Cited by 21
He, F., Wang, F., Yang, J., & Yang, S. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5834293 · Cited by 18
Immunotherapeutic advances in gastric cancer
Yoneda, A., Kuroki, T., & Eguchi, S. (2021) · Surgery Today · doi:10.1007/s00595-021-02236-2 · Cited by 17
Satake, H., Kondo, M., Mizumoto, M., Kotake, T., Okita, Y., Ogata, T., Hatachi, Y., Yasui, H., Miki, A., Imai, Y., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11742 · Cited by 5
Cited by
GastroBot: a Chinese gastrointestinal disease chatbot based on the retrieval-augmented generation
Zhou, Q., Liu, C., Duan, Y., Sun, K., Li, Y., Kan, H., Gu, Z., Shu, J., & Hu, J. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1392555 · Cited by 44
“This study focuses on the application of RAG in the field of clinical gastroenterology in China, aiming to address the issue associated with the continuous increase in the infection rate of Helicobacter pylori and the rising incidence of gastric cancer (23, 24).”
Background
Metadata
- Authors
- Yang, W.-J., Zhao, H.-P., Yu, Y., Wang, J.-H., Guo, L., Liu, J.-Y., Pu, J., & Lv, J.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2023-04-28
- Volume
- 29
- Issue
- 16
- Pages
- 2452-2468
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W4366780660
- Cited by
- 513
- References
- 121
- FWCI
- 81.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.